Related Experiment Video

Updated: Mar 14, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

14.2K

ZIC5 Drives Melanoma Aggressiveness by PDGFD-Mediated Activation of FAK and STAT3

Reiko Satow1,2, Tomomi Nakamura1, Chiaki Kato1

  • 1Laboratory of Genome and Biosignals, Tokyo University of Pharmacy and Life Sciences, Hachioji-shi, Tokyo, Japan.

Cancer Research
|September 28, 2016
PubMed

Insights

ZIC5 drives melanoma drug resistance by suppressing E-cadherin and activating PDGFD, FAK, and STAT3 signaling. Targeting ZIC5 or PDGFD may overcome resistance to BRAF inhibitors in melanoma treatment.

Area of Science:

  • Oncology
  • Cancer Biology
  • Melanoma Research

Background:

  • Drug resistance limits the efficacy of cancer therapies.
  • Understanding resistance mechanisms is crucial for improving melanoma treatment.
  • Melanoma arises from neural crest-derived melanocytes, suggesting shared developmental pathways.

Purpose of the Study:

  • To identify genes mediating drug resistance in melanoma.
  • To investigate the role of ZIC5 in melanoma development and drug resistance.
  • To elucidate the signaling pathways regulated by ZIC5 in melanoma.

Main Methods:

  • siRNA screening of genes involved in neural crest cell development.
  • Expression analysis of ZIC5 in human melanoma.
  • Assessment of ZIC5 effects on melanoma cell proliferation, survival, and drug resistance.
  • Microarray analysis to identify ZIC5 downstream targets.
  • Inhibition studies targeting ZIC5, PDGFD, FAK, and STAT3.

Main Results:

  • ZIC5 was identified as a mediator of melanoma drug resistance.
  • ZIC5 enhances melanoma proliferation, survival, growth, metastasis, and drug resistance.
  • ZIC5 activates PDGFD, FAK, and STAT3 signaling, contributing to drug resistance.
  • Silencing ZIC5 or PDGFD sensitized melanoma cells to BRAF inhibitors.
  • A positive feedback loop involving PDGFD, FAK, and STAT3 regulates ZIC5 expression.

Conclusions:

  • ZIC5 is a key driver of melanoma drug resistance.
  • Targeting ZIC5 and its downstream signaling pathways (PDGFD, FAK, STAT3) offers a potential strategy to overcome drug resistance.
  • ZIC5 and PDGFD are promising therapeutic targets for enhancing melanoma treatment efficacy.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.7K

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K